Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival

1 month ago 30

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s move for a lot less money.

Read Entire Article

Pfizer makes a $6 billion run into a new cancer drug race, 6 months after rival

Related

OPEC+ to boost oil production even more than expected in Aug...

Delta kicks off second-quarter earnings this week. But is 20...

‘She’s in a shaky marriage that could soon end’: Will my dau...

Trending

Popular

Watch these XRP levels as price meets ‘turning point’

Malaysian regulator proposes easing crypto asset listing pro...

Where are we in the Bitcoin cycle? Analyst Lyn Alden shares ...

Record Q2, monthly close next? 5 things to know in Bitcoin t...

Crypto ETP inflows in H1 2025 down 2.7% from last year’s $18...